Intracranial hemorrhage

 Our last NeuroMeetup talk of the year will be dedicated to Intracranial hemorrhage.

First speaker: Martina Göldlin, MD (Inselspital Bern)

"Risk factors and mechanisms of primary intracerebral haemorrhage from a clinical research perspective".

Intracerebral haemorrhage (ICH) is a devastating disease with few  evidence-based therapeutic options, high morbidity and mortality.  Understanding the risk factors and underlying mechanisms is key to  improve future research approaches  for prevention and therapy of ICH. This talk will provide insights from  a clinical research perspective. 

Second speaker: Kevin Akeret, MD (University Hospital Zurich)

"The pathophysiology of secondary brain damage after intracerebral hemorrhage and potential therapeutic targets". 

After intracerebral hemorrhage, patients often deteriorate within days  to a few weeks due to the development of secondary brain damage.  Secondary neurodamage after intracerebral haemorrhage has a complex  multiphasic pathopysiology. A better understanding of its individual  phases, identification of its mediators and specific therapeutic  targeting of such has the potential to minimize the development of  secondary brain damage after intracerebral hemorrhage and to improve  patient outcome.